114 related articles for article (PubMed ID: 14761202)
1. Synthesis of flexible sulfur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malignant and benign cells.
Liu S; Brown CW; Berlin KD; Dhar A; Guruswamy S; Brown D; Gardner GJ; Birrer MJ; Benbrook DM
J Med Chem; 2004 Feb; 47(4):999-1007. PubMed ID: 14761202
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, structure-activity relationships, and RARgamma-ligand interactions of nitrogen heteroarotinoids.
Dhar A; Liu S; Klucik J; Berlin KD; Madler MM; Lu S; Ivey RT; Zacheis D; Brown CW; Nelson EC; Birckbichler PJ; Benbrook DM
J Med Chem; 1999 Sep; 42(18):3602-14. PubMed ID: 10479291
[TBL] [Abstract][Full Text] [Related]
3. Biologically active heteroarotinoids exhibiting anticancer activity and decreased toxicity.
Benbrook DM; Madler MM; Spruce LW; Birckbichler PJ; Nelson EC; Subramanian S; Weerasekare GM; Gale JB; Patterson MK; Wang B; Wang W; Lu S; Rowland TC; DiSivestro P; Lindamood C; Hill DL; Berlin KD
J Med Chem; 1997 Oct; 40(22):3567-83. PubMed ID: 9357524
[TBL] [Abstract][Full Text] [Related]
4. Effects of retinoids on cancerous phenotype and apoptosis in organotypic cultures of ovarian carcinoma.
Guruswamy S; Lightfoot S; Gold MA; Hassan R; Berlin KD; Ivey RT; Benbrook DM
J Natl Cancer Inst; 2001 Apr; 93(7):516-25. PubMed ID: 11287445
[TBL] [Abstract][Full Text] [Related]
5. Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.
Zacheis D; Dhar A; Lu S; Madler MM; Klucik J; Brown CW; Liu S; Clement F; Subramanian S; Weerasekare GM; Berlin KD; Gold MA; Houck JR; Fountain KR; Benbrook DM
J Med Chem; 1999 Oct; 42(21):4434-45. PubMed ID: 10543887
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of heteroarotinoids demonstrate structure specificity relationships.
Benbrook DM; Subramanian S; Gale JB; Liu S; Brown CW; Boehm MF; Berlin KD
J Med Chem; 1998 Sep; 41(19):3753-7. PubMed ID: 9733501
[TBL] [Abstract][Full Text] [Related]
7. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
[TBL] [Abstract][Full Text] [Related]
8. Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists.
Benbrook DM; Kamelle SA; Guruswamy SB; Lightfoot SA; Rutledge TL; Gould NS; Hannafon BN; Dunn ST; Berlin KD
Invest New Drugs; 2005 Oct; 23(5):417-28. PubMed ID: 16133793
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the mechanism of induction of apoptosis in ovarian carcinoma cells by the conformationally restricted synthetic retinoids CD437 and 4-HPR.
Holmes WF; Soprano DR; Soprano KJ
J Cell Biochem; 2003 May; 89(2):262-78. PubMed ID: 12704790
[TBL] [Abstract][Full Text] [Related]
10. A novel atypical retinoid endowed with proapoptotic and antitumor activity.
Cincinelli R; Dallavalle S; Merlini L; Penco S; Pisano C; Carminati P; Giannini G; Vesci L; Gaetano C; Illy B; Zuco V; Supino R; Zunino F
J Med Chem; 2003 Mar; 46(6):909-12. PubMed ID: 12620066
[TBL] [Abstract][Full Text] [Related]
11. Synthetic retinoids as inducers of apoptosis in ovarian carcinoma cell lines.
Holmes WF; Soprano DR; Soprano KJ
J Cell Physiol; 2004 Jun; 199(3):317-29. PubMed ID: 15095280
[TBL] [Abstract][Full Text] [Related]
12. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells.
Chen Y; Dokmanovic M; Stein WD; Ardecky RJ; Roninson IB
Cancer Res; 2006 Sep; 66(17):8749-61. PubMed ID: 16951191
[TBL] [Abstract][Full Text] [Related]
13. Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells.
Appierto V; Villani MG; Cavadini E; Gariboldi M; De Cecco L; Pierotti MA; Lambert JR; Reid J; Tiberio P; Colombo N; Formelli F
Oncogene; 2007 Jun; 26(27):3952-62. PubMed ID: 17213814
[TBL] [Abstract][Full Text] [Related]
14. Novel heteroarotinoids as potential antagonists of Mycobacterium bovis BCG.
Brown CW; Liu S; Klucik J; Berlin KD; Brennan PJ; Kaur D; Benbrook DM
J Med Chem; 2004 Feb; 47(4):1008-17. PubMed ID: 14761203
[TBL] [Abstract][Full Text] [Related]
15. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH
Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828
[TBL] [Abstract][Full Text] [Related]
16. [Synthesis of retinoids with a modified polar group and their antitumor activity. Report I].
Deriabina EL; Khodonov AA; Cherevataia GV; Kirillova IuG; Shvets VI; Kostanian IA; Astapova MV; Dranitsyna SM; Starovoĭtova EV
Bioorg Khim; 1995 Dec; 21(12):941-9. PubMed ID: 8602891
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of a new series of retinoid-related biphenyl-4-ylacrylic acids endowed with antiproliferative and proapoptotic activity.
Cincinelli R; Dallavalle S; Nannei R; Carella S; De Zani D; Merlini L; Penco S; Garattini E; Giannini G; Pisano C; Vesci L; Carminati P; Zuco V; Zanchi C; Zunino F
J Med Chem; 2005 Jul; 48(15):4931-46. PubMed ID: 16033272
[TBL] [Abstract][Full Text] [Related]
18. Retinoids and malignant melanoma: a pathway of proliferation inhibition on SK MEL28 cell line.
Emionite L; Galmozzi F; Raffo P; Vergani L; Toma S
Anticancer Res; 2003; 23(1A):13-9. PubMed ID: 12680189
[TBL] [Abstract][Full Text] [Related]
19. In vitro antitumor potential of 4-BPRE, a butyryl aminophenyl ester of retinoic acid: role of the butyryl group.
Um SJ; Han HS; Kwon YJ; Park SH; Bae TS; Rho YS; Sin HS
Oncol Rep; 2004 Mar; 11(3):719-26. PubMed ID: 14767528
[TBL] [Abstract][Full Text] [Related]
20. Receptor-selective retinoids inhibit the growth of normal and malignant breast cells by inducing G1 cell cycle blockade.
Wu K; DuPré E; Kim H; Tin-U CK; Bissonnette RP; Lamph WW; Brown PH
Breast Cancer Res Treat; 2006 Mar; 96(2):147-57. PubMed ID: 16273314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
